UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE)

Donnan, PT; McLernon, D; Steinke, D; Ryder, S; Roderick, P; Sullivan, FM; Rosenberg, W; (2007) Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE). BMC Health Services Research , 7 , Article 54. 10.1186/1472-6963-7-54. Green open access

[img]
Preview
PDF
1472-6963-7-54.pdf

Download (297kB)
[img] MS Word (Additional File 1: Appendix 1. Indications for liver function tests with no obvious liver disease, and consequent investigations )
1472-6963-7-54-s1.doc

Download (54kB)
[img] MS Word (Additional File 2: Appendix 2. Possible Outcomes following abnormal liver function tests)
1472-6963-7-54-s2.doc

Download (71kB)
[img] MS Word (Additional File 3: Appendix 3. ICD9/ICD10 codes for liver disease, comorbidities and other outcomes)
1472-6963-7-54-s3.doc

Download (91kB)

Abstract

Liver function tests (LFTs) are routinely performed in primary care, and are often the gateway to further invasive and/or expensive investigations. Little is known of the consequences in people with an initial abnormal liver function (ALF) test in primary care and with no obvious liver disease. Further investigations may be dangerous for the patient and expensive for Health Services. The aims of this study are to determine the natural history of abnormalities in LFTs before overt liver disease presents in the population and identify those who require minimal further investigations with the potential for reduction in NHS costs.

Type: Article
Title: Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE)
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1186/1472-6963-7-54
Publisher version: http://dx.doi.org/10.1186/1472-6963-7-54
Language: English
Additional information: © 2007 Donnan et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. PMCID: PMC1868021
Keywords: Adolescent, Adult, Aged, Cost-Benefit Analysis, Decision Support Techniques, Female, Humans, Incidence, Liver Diseases, Liver Function Tests, Male, Medical Records Systems, Computerized, Reference Values, Registries, Retrospective Studies, Scotland
UCL classification: UCL > School of Life and Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of)
URI: http://discovery.ucl.ac.uk/id/eprint/1340648
Downloads since deposit
29Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item